{"doc_id": "PMC-2626671-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["Antibodies", "and", "reagents", "."], "sentence": "Antibodies and reagents .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2626671-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S2", "tokens": ["The", "following", "antibodies", "used", "for", "intracellular", "or", "surface", "stains", "were", "obtained", "from", "eBioscience", ":", "anti", "-", "IL-2", ",", "anti", "-", "IFN-gamma", ",", "anti", "-", "TNF", ",", "anti", "-", "granzyme", "B", ",", "anti", "-", "CD8", ",", "anti", "-", "CD25", ",", "and", "anti", "-", "CD44", "."], "sentence": "The following antibodies used for intracellular or surface stains were obtained from eBioscience : anti - IL-2 , anti - IFN-gamma , anti - TNF , anti - granzyme B , anti - CD8 , anti - CD25 , and anti - CD44 .", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "IL-2", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T2", "text": "IFN-gamma", "entity_type": "Protein", "start": 20, "end": 20}, {"id": "T3", "text": "TNF", "entity_type": "Protein", "start": 24, "end": 24}, {"id": "T4", "text": "granzyme B", "entity_type": "Protein", "start": 28, "end": 29}, {"id": "T5", "text": "CD8", "entity_type": "Protein", "start": 33, "end": 33}, {"id": "T6", "text": "CD25", "entity_type": "Protein", "start": 37, "end": 37}, {"id": "T7", "text": "CD44", "entity_type": "Protein", "start": 42, "end": 42}]}
{"doc_id": "PMC-2626671-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S3", "tokens": ["Anti", "-", "CD69", "was", "purchased", "from", "BD", "."], "sentence": "Anti - CD69 was purchased from BD .", "event_mentions": [], "entity_mentions": [{"id": "T8", "text": "CD69", "entity_type": "Protein", "start": 2, "end": 2}]}
{"doc_id": "PMC-2626671-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S4", "tokens": ["For", "ChIP", "experiments", ",", "the", "anti", "-", "Eomes", "antibody", "was", "obtained", "from", "Abcam", "and", "the", "anti", "-", "Runx3", "antibody", "was", "produced", "by", "the", "Groner", "laboratory", "."], "sentence": "For ChIP experiments , the anti - Eomes antibody was obtained from Abcam and the anti - Runx3 antibody was produced by the Groner laboratory .", "event_mentions": [], "entity_mentions": [{"id": "T9", "text": "Eomes", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T10", "text": "Runx3", "entity_type": "Protein", "start": 17, "end": 17}]}
{"doc_id": "PMC-2626671-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S5", "tokens": ["The", "following", "antibodies", "were", "used", "for", "immunoblotting", ":", "anti", "perforin", "(", "Abcam", ")", ",", "anti", "-", "Eomes", "(", "Abcam", ")", ",", "and", "anti-Pol-II", "(", "Santa", "Cruz", "Biotechnology", ",", "Inc", ".", ")", "."], "sentence": "The following antibodies were used for immunoblotting : anti perforin ( Abcam ) , anti - Eomes ( Abcam ) , and anti-Pol-II ( Santa Cruz Biotechnology , Inc . ) .", "event_mentions": [], "entity_mentions": [{"id": "T11", "text": "perforin", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T12", "text": "Eomes", "entity_type": "Protein", "start": 16, "end": 16}]}
{"doc_id": "PMC-2626671-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S6", "tokens": ["The", "T-bet", "antibody", "was", "provided", "by", "L", ".", "Glimcher", "(", "Harvard", "School", "of", "Public", "Health", ",", "Boston", ",", "MA", ")", "."], "sentence": "The T-bet antibody was provided by L . Glimcher ( Harvard School of Public Health , Boston , MA ) .", "event_mentions": [], "entity_mentions": [{"id": "T13", "text": "T-bet", "entity_type": "Protein", "start": 1, "end": 1}]}
{"doc_id": "PMC-2626671-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "S7", "tokens": ["The", "following", "reagents", "were", "used", "for", "the", "experiments", "presented", "in", "this", "report", ":", "Annexin", "V", "-", "FITC", "Apoptosis", "Detection", "Kit", "(", "BD", ")", ",", "CD8", "Negative", "Isolation", "Kit", "(", "Invitrogen", ")", ",", "CD8", "MicroBeads", "(", "Miltenyi", "Biotec", ")", ",", "and", "SYBR", "Green", "PCR", "Core", "Reagents", "(", "Applied", "Biosystems", ")", "."], "sentence": "The following reagents were used for the experiments presented in this report : Annexin V - FITC Apoptosis Detection Kit ( BD ) , CD8 Negative Isolation Kit ( Invitrogen ) , CD8 MicroBeads ( Miltenyi Biotec ) , and SYBR Green PCR Core Reagents ( Applied Biosystems ) .", "event_mentions": [], "entity_mentions": [{"id": "T14", "text": "Annexin V", "entity_type": "Protein", "start": 13, "end": 14}, {"id": "T15", "text": "CD8", "entity_type": "Protein", "start": 24, "end": 24}, {"id": "T16", "text": "CD8", "entity_type": "Protein", "start": 32, "end": 32}]}
{"doc_id": "PMC-2626671-08-MATERIALS_AND_METHODS-01.txt", "sent_id": "", "tokens": ["The", "Gp33", "peptide", "(", "KAVYNFATC", ")", "was", "synthesized", "by", "the", "Tufts", "University", "Core", "Facility", ",", "and", "10", "mM", "of", "stock", "solutions", "was", "prepared", "in", "DMSO", "."], "sentence": "The Gp33 peptide ( KAVYNFATC ) was synthesized by the Tufts University Core Facility , and 10 mM of stock solutions was prepared in DMSO .", "event_mentions": [], "entity_mentions": []}
